Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Cash from Investing Activities (2024 - 2025)

Historic Cash from Investing Activities for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $9.5 million.

  • Beta Bionics' Cash from Investing Activities fell 3776.41% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$193.1 million, marking a year-over-year change of. This contributed to the annual value of -$3.5 million for FY2024, which is 9501.24% up from last year.
  • According to the latest figures from Q3 2025, Beta Bionics' Cash from Investing Activities is $9.5 million, which was down 3776.41% from $6.2 million recorded in Q2 2025.
  • Beta Bionics' Cash from Investing Activities' 5-year high stood at $15.2 million during Q3 2024, with a 5-year trough of -$179.1 million in Q1 2025.